Latest prostate cancer News

AstraZeneca aims to transform cancer care with practice-changing data at ASCO 2022
Fast-tracked: First in-human trial for aggressive brain tumours
Specialist Nurses close care gap for men with prostate cancer
10 years of leadership and care: Meet nurses who have gone distance
Australian researchers in race to prevent prostate cancer deaths
PCFA champion: Meet PCSN Julie Sykes
Tumor release of lactate forces nearby cells into supportive role
Prostate Cancer Social Group? John and Pat are leading way
Genetic strength in numbers
What’s for dinner?
Government subsidy accelerates new era in prostate cancer treatment
Finding your place of peace
Taking Melanoma Nurses National
John Daven chats support groups, prostate cancer and life
PCFA welcomes listing of PSMA PET/CT scanning
$600,000 funding boost for prostate cancer research
We need to do more to save men’s lives
Budget backs review of prostate cancer guidelines
It can happen to anybody
Penile traction therapy
Two friends and one lasting legacy
Covering Last Mile to Cure: Consumer Advocacy Discussion Forums
Stronger for Longer Scholarships support QUT’s ground-breaking prostate cancer research
Regaining continence after prostate cancer: Help is here
Postcard from Geelong: Meet Bill Rebula
Q&A with Bill Rebula Geelong Prostate Cancer Support Group Convenor
In Memory of Emeritus Professor Pamela Russell AM
24-hr Gippsland pedal to power prostate cancer research
Prostate Health Index Density
Lynparza plus abiraterone reduced risk of disease progression by 34% vs. standard-of-care in 1st-line metastatic
Applied Molecular Therapies launches its first theranostic product in prostate cancer treatment
Pancare Foundation launches initiatives to help people diagnosed with rare biliary cancer
Generous community donates more than $400,000 for WA cancer research
Forget-him-not this Valentine’s Day
One year of telenursing
10 years on: Reflections from survivor
Advanced prostate cancer antibody drug shows success in pet dogs
COVID breath test among 24 innovative projects backed to commercialise
New blood test combined with image-based prostate cancer screening reduces harms and costs
First patient dosed in Telix ‘ProstACT’ therapeutic program
Male carriers of BRCA1 and BRCA2 gene mutation also at risk of multiple cancers: study
Leading Queensland cancer specialist recognised in Australia Day honours
Significant capital raise for emerging Australian company
How data can help prevent overdiagnosis
Artificial intelligence equal to diagnosing prostate cancer, study finds
Large international evaluation shows AI accurately diagnoses prostate cancer
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data
New Year A-Team fundraising challenge set to be lifesaver